Kepler Capital analyst William Mackie maintained a Buy rating on Siemens Healthineers AG (SEMHF) today and set a price target of EUR52.00. The company’s shares closed last Monday at $58.20, close to its 52-week high of $60.50.
According to TipRanks.com, Mackie is a 3-star analyst with an average return of 2.6% and a 62.3% success rate. Mackie covers the Industrial Goods sector, focusing on stocks such as Siemens Energy, Siemens AG, and ABB.
Currently, the analyst consensus on Siemens Healthineers AG is a Moderate Buy with an average price target of $61.12, implying a 5.0% upside from current levels. In a report issued on April 20, J.P. Morgan also maintained a Buy rating on the stock with a EUR55.30 price target.
See today’s analyst top recommended stocks >>
Based on Siemens Healthineers AG’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.87 billion and net profit of $432 million. In comparison, last year the company earned revenue of $3.59 billion and had a net profit of $301 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.